- Home
- EVMN vs ARQQ Comparison
EVMN vs ARQQ Comparison
Compare EVMN & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | ARQQ |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.2M | 348.7M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EVMN | ARQQ |
|---|---|---|
| Price | $12.48 | $18.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $43.88 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 445.8K | 241.9K |
| Earning Date | 06-11-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,000,000.00 | N/A |
| Revenue This Year | N/A | $381.13 |
| Revenue Next Year | N/A | $212.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 85.71 | N/A |
| 52 Week Low | $10.47 | $11.52 |
| 52 Week High | $33.20 | $62.00 |
Technical Indicators
Market Signals| Indicator | EVMN | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 42.18 |
| Support Level | $12.07 | $15.50 |
| Resistance Level | $15.06 | $19.19 |
| Average True Range (ATR) | 0.70 | 1.43 |
| MACD | -0.10 | -0.41 |
| Stochastic Oscillator | 4.36 | 2.54 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.